PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 113 filers reported holding PTC THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $36,000 | -75.5% | 700 | -78.8% | 0.01% | -86.7% |
| Q1 2020 | $147,000 | +30.1% | 3,299 | +31.4% | 0.08% | +127.3% |
| Q2 2019 | $113,000 | -37.9% | 2,511 | -49.8% | 0.03% | +37.5% |
| Q1 2019 | $182,000 | +468.8% | 5,000 | +400.0% | 0.02% | +140.0% |
| Q4 2018 | $32,000 | -60.5% | 1,000 | -77.3% | 0.01% | -16.7% |
| Q2 2017 | $81,000 | -83.2% | 4,412 | -94.1% | 0.01% | -78.2% |
| Q1 2016 | $481,000 | +49.4% | 74,647 | +1014.1% | 0.06% | +27.9% |
| Q2 2015 | $322,000 | – | 6,700 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,750,000 | $84,053,000 | 7.32% |
| RTW INVESTMENTS, LP | 3,832,480 | $184,074,000 | 6.94% |
| Burrage Capital Management LLC | 195,725 | $9,401,000 | 6.30% |
| Asymmetry Capital Management, L.P. | 55,408 | $2,661,000 | 4.77% |
| SECTORAL ASSET MANAGEMENT INC | 328,738 | $15,789,000 | 2.36% |
| ARMISTICE CAPITAL, LLC | 758,000 | $36,407,000 | 2.10% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 114,000 | $5,470,000 | 1.97% |
| Opaleye Management Inc. | 191,000 | $9,174,000 | 1.80% |
| Sofinnova Investments, Inc. | 517,092 | $24,836,000 | 1.79% |
| Chubb Ltd | 8,180 | $393,000 | 1.68% |